| Human host factors required for influenza virus replication R König, S Stertz, Y Zhou, A Inoue, HH Hoffmann, S Bhattacharyya, ... Nature 463 (7282), 813-817, 2010 | 963 | 2010 |
| Meta-and orthogonal integration of influenza “OMICs” data defines a role for UBR4 in virus budding S Tripathi, MO Pohl, Y Zhou, A Rodriguez-Frandsen, G Wang, DA Stein, ... Cell host & microbe 18 (6), 723-735, 2015 | 903 | 2015 |
| The intracellular sites of early replication and budding of SARS-coronavirus S Stertz, M Reichelt, M Spiegel, T Kuri, L Martínez-Sobrido, ... Virology 361 (2), 304-315, 2007 | 460 | 2007 |
| Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling D Holzinger, C Jorns, S Stertz, S Boisson-Dupuis, R Thimme, ... Journal of virology 81 (14), 7776-7785, 2007 | 288 | 2007 |
| Entry of influenza A virus: host factors and antiviral targets TO Edinger, MO Pohl, S Stertz Journal of General Virology 95 (2), 263-277, 2014 | 278 | 2014 |
| The Mx GTPase family of interferon-induced antiviral proteins O Haller, S Stertz, G Kochs Microbes and infection 9 (14-15), 1636-1643, 2007 | 237 | 2007 |
| Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines B Manicassamy, RA Medina, R Hai, T Tsibane, S Stertz, E Nistal-Villan, ... PLoS pathogens 6 (1), e1000745, 2010 | 218 | 2010 |
| Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase J Dittmann, S Stertz, D Grimm, J Steel, A García-Sastre, O Haller, G Kochs Journal of virology 82 (7), 3624-3631, 2008 | 208 | 2008 |
| Missorting of LaCrosse virus nucleocapsid protein by the interferon‐induced MxA GTPase involves smooth ER membranes M Reichelt, S Stertz, J Krijnse‐Locker, O Haller, G Kochs Traffic 5 (10), 772-784, 2004 | 155 | 2004 |
| Antiviral activity of type I, II, and III interferons counterbalances ACE2 inducibility and restricts SARS-CoV-2 I Busnadiego, S Fernbach, MO Pohl, U Karakus, M Huber, A Trkola, ... MBio 11 (5), 10.1128/mbio. 01928-20, 2020 | 145 | 2020 |
| Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses RA Medina, S Stertz, B Manicassamy, P Zimmermann, X Sun, RA Albrecht, ... Science translational medicine 5 (187), 187ra70-187ra70, 2013 | 144 | 2013 |
| MHC class II proteins mediate cross-species entry of bat influenza viruses U Karakus, T Thamamongood, K Ciminski, W Ran, SC Günther, MO Pohl, ... Nature 567 (7746), 109-112, 2019 | 120 | 2019 |
| Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models CW Seibert, M Kaminski, J Philipp, D Rubbenstroth, RA Albrecht, ... Journal of virology 84 (21), 11219-11226, 2010 | 109 | 2010 |
| Uncovering the global host cell requirements for influenza virus replication via RNAi screening S Stertz, ML Shaw Microbes and infection 13 (5), 516-525, 2011 | 107 | 2011 |
| Interferon-induced, antiviral human MxA protein localizes to a distinct subcompartment of the smooth endoplasmic reticulum S Stertz, M Reichelt, J Krijnse-Locker, J Mackenzie, JC Simpson, O Haller, ... Journal of interferon & cytokine research 26 (9), 650-660, 2006 | 96 | 2006 |
| Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus RA Medina, B Manicassamy, S Stertz, CW Seibert, R Hai, RB Belshe, ... Nature communications 1 (1), 28, 2010 | 87 | 2010 |
| An antiviral trap made of protein nanofibrils and iron oxyhydroxide nanoparticles A Palika, A Armanious, A Rahimi, C Medaglia, M Gasbarri, S Handschin, ... Nature Nanotechnology 16 (8), 918-925, 2021 | 64 | 2021 |
| SARS-CoV-2 variants reveal features critical for replication in primary human cells MO Pohl, I Busnadiego, V Kufner, I Glas, U Karakus, S Schmutz, M Zaheri, ... PLoS biology 19 (3), e3001006, 2021 | 56 | 2021 |
| TIGIT limits immune pathology during viral infections M Schorer, N Rakebrandt, K Lambert, A Hunziker, K Pallmer, A Oxenius, ... Nature Communications 11 (1), 1288, 2020 | 53 | 2020 |
| Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target E Yángüez, A Hunziker, MP Dobay, S Yildiz, S Schading, E Elshina, ... Nature communications 9 (1), 3679, 2018 | 53 | 2018 |
